Venous Access Port Sales

Venous Access Port Sales Market Outlook

The global venous access port market is projected to reach approximately USD 2.5 billion by 2035, growing at a compound annual growth rate (CAGR) of 7.5% during the forecast period from 2025 to 2035. This significant growth can be attributed to the increasing prevalence of chronic diseases and the rising number of patients requiring long-term intravenous access for treatments such as chemotherapy and parenteral nutrition. Additionally, advancements in technology, such as the development of bio-compatible materials and innovative designs, are expected to enhance the safety and efficiency of venous access ports, further driving market growth. The increasing geriatric population, which often requires multiple therapeutic interventions, also plays a crucial role in boosting demand for venous access solutions. The growing emphasis on patient-centric care and the rising adoption of minimally invasive procedures are anticipated to create new opportunities in the market.

Growth Factor of the Market

The venous access port market is experiencing robust growth due to several key factors. Firstly, the rise in chronic diseases such as cancer, diabetes, and cardiovascular diseases has led to higher demand for consistent intravenous access, which venous access ports provide. Secondly, the growing focus on outpatient care has prompted healthcare facilities to adopt more efficient and durable venous access devices that can be managed outside of hospital settings. Additionally, technological advancements in the design and materials used in venous access ports have contributed to improved patient comfort and reduced complications, thereby promoting their adoption among healthcare providers. Furthermore, the increasing awareness about the benefits of venous access ports over traditional methods, such as peripheral catheters, is driving market growth. Lastly, supportive government initiatives aimed at improving healthcare infrastructure and access to advanced medical technologies are likely to further propel demand for venous access ports in the coming years.

Key Highlights of the Market

• The market is expected to reach USD 2.5 billion by 2035 with a CAGR of 7.5%.
• Increasing prevalence of chronic illnesses is a major driving force for market growth.
• Technological innovations are enhancing the safety and efficiency of venous access ports.
• Rising outpatient care demand is influencing the adoption of durable venous access devices.
• Government initiatives are fostering improved healthcare infrastructure and accessibility.

By Product Type

Single-Lumen Ports:

Single-lumen ports are among the most common types of venous access ports used in medical settings. These ports are designed for delivering medications, fluids, and blood products through a single access point, making them ideal for patients requiring only one line of access. The simplicity of single-lumen ports leads to easier management and fewer complications associated with multiple lines. As a result, healthcare providers often prefer these ports for patients undergoing chemotherapy or other treatments requiring intermittent access. The growing patient population with conditions necessitating single-lumen ports will likely drive the segment's growth during the forecast period.

Double-Lumen Ports:

Double-lumen ports offer the advantage of providing two separate channels for medication or fluid administration, allowing for concurrent infusions. This feature is particularly beneficial for patients who require simultaneous treatments or have different medication protocols that cannot be mixed. The double-lumen ports are extensively used in oncology and critical care settings due to their ability to reduce the frequency of needle punctures, thereby minimizing the risk of complications such as catheter-related infections. With the rising incidence of diseases that require complex treatment regimens, the demand for double-lumen ports is expected to grow significantly in the coming years.

Implantable Ports:

Implantable ports are designed to be placed beneath the skin, providing a long-term solution for patients who need repeated vascular access over extended periods. These ports are particularly useful for individuals undergoing long-term chemotherapy or parenteral nutrition, as they reduce the need for multiple venipunctures and enhance patient comfort. The growing trend of outpatient care and advancements in surgical techniques have further facilitated the adoption of implantable ports. As healthcare providers continue to prioritize patient-centric solutions, the segment of implantable ports is anticipated to witness steady growth due to their advantages in long-term care scenarios.

External Ports:

External ports are designed to provide temporary access for patients requiring short-term intravenous therapy. These ports are often used in acute care settings where quick access to the venous system is necessary. External ports can be easily placed and removed, making them suitable for procedures that require immediate access, such as emergency blood transfusions or medication administration. While the demand for external ports may not be as high as that for implantable ports, their significance in urgent care settings ensures a steady market presence. The growing number of emergency cases and the need for quick interventions will sustain the relevance of external ports in the venous access market.

Others:

This category includes various specialized ports designed for unique applications and patient needs, such as pediatric ports or ports with advanced materials. These ports often cater to specific healthcare environments or patient demographics, which necessitate tailored solutions. The development of innovative port designs that address unique challenges faced by certain patient groups, such as children or those with sensitive skin, is driving growth in this segment. As healthcare providers seek to enhance treatment outcomes through personalized medical devices, the "Others" category of venous access ports is expected to gain traction in the overall market.

By Application

Chemotherapy:

Chemotherapy is one of the primary applications for venous access ports, as it typically requires frequent and prolonged intravenous access. Patients undergoing chemotherapy often experience difficult venous access due to the effects of the treatment, such as vein scarring or collapse, making ports an essential solution. The need for reliable access to the vascular system for the administration of chemotherapeutic agents drives the demand for venous access ports in oncology settings. As the global cancer incidence continues to rise, the segment of chemotherapy application within the venous access port market is expected to expand significantly, contributing to overall market growth.

Parenteral Nutrition:

Parenteral nutrition is an essential treatment for patients who are unable to consume food orally or through enteral routes. Venous access ports are crucial in providing long-term intravenous nutrition, ensuring that patients receive the necessary nutrients without the complications associated with frequent venipunctures. As the incidence of gastrointestinal diseases and conditions necessitating parenteral nutrition increases, the demand for venous access ports will remain strong. This segment is particularly relevant in critical care and home healthcare settings, where patient needs often dictate the requirement for sustained nutritional support via venous access devices.

Blood Transfusions:

Blood transfusions are another critical application for venous access ports, especially in patients requiring recurrent transfusions due to conditions like anemia or blood disorders. Ports enable healthcare providers to administer blood products efficiently and safely, reducing the stress and complications associated with multiple needle sticks. As blood transfusion procedures become more common in various healthcare settings, the relevance of venous access ports for this application will continue to grow. Additionally, the emphasis on improving patient comfort and minimizing the risk of infection is further solidifying the role of ports in blood transfusion practices.

Antibiotic Therapy:

Patients undergoing long-term antibiotic therapy, particularly those with chronic infections or complex medical conditions, benefit significantly from venous access ports. These ports provide a reliable means to deliver medication over extended periods while minimizing the risk of complications associated with peripheral access. The increasing prevalence of antibiotic-resistant infections and the corresponding need for sustained treatment will likely drive the demand for venous access ports in this application. As healthcare providers continue to adopt effective strategies for managing chronic infections, the segment of antibiotic therapy will remain a key driver of market growth.

Others:

This category encompasses various other applications where venous access ports are utilized, including administration of intravenous fluids, pain management, and specific therapies for complex medical conditions. The versatility of venous access ports allows them to be employed in a range of therapeutic scenarios, catering to individual patient needs. As the healthcare landscape evolves with more personalized treatment approaches, the demand for specialized applications of venous access ports is likely to increase. This segment serves as a testament to the adaptability of venous access devices, ensuring they remain relevant across a wide array of medical settings.

By Distribution Channel

Hospitals:

Hospitals are the primary distribution channel for venous access ports, accounting for a significant share of the market. In hospital settings, venous access ports are essential for patient management, particularly in surgical, oncology, and critical care departments. Hospitals prioritize the use of high-quality ports that ensure patient safety and comfort, leading to strategic partnerships with manufacturers to secure the latest innovations. The increasing patient volume in hospitals, driven by the rise in chronic diseases and surgical procedures, is expected to sustain the demand for venous access ports in this distribution channel. Hospitals are also investing in training healthcare professionals to effectively manage and care for patients with venous access devices, further solidifying their role in the market.

Specialty Clinics:

Specialty clinics, which focus on specific medical fields such as oncology or nephrology, are increasingly utilizing venous access ports to enhance patient care. These clinics often require specialized equipment for targeted treatments, and venous access ports provide a reliable solution for administering therapies while minimizing patient discomfort. As more patients seek treatment at specialty clinics, the demand for venous access ports in these settings is expected to grow. The rise of outpatient services and the emphasis on personalized medicine will further drive the adoption of venous access devices in specialty clinics, positioning them as a vital distribution channel in the market.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining popularity as alternatives to traditional hospitals for outpatient procedures, and they frequently utilize venous access ports for various surgical interventions. These centers benefit from the efficiency and convenience that ports offer, enabling quick access to the vascular system for drug administration or fluid management during procedures. As ASCs continue to expand and provide a broader range of surgical services, the demand for venous access ports in these facilities is likely to increase. The focus on cost-effective healthcare solutions and the growing trend of outpatient procedures are driving the adoption of venous access devices in ambulatory surgical centers.

Homecare Settings:

Homecare settings represent a rapidly growing distribution channel for venous access ports, especially with the increasing focus on patient-centered care and the shift towards delivering healthcare in home environments. Patients requiring long-term intravenous treatments, such as those receiving parenteral nutrition or antibiotic therapy, benefit from having ports that allow for self-administration or caregiver-assisted administration at home. The convenience and comfort of using venous access ports in homecare settings are compelling factors driving demand in this segment. As the population ages and the prevalence of chronic conditions rises, the need for home-based healthcare solutions is expected to bolster the market for venous access ports in homecare environments.

Others:

This category includes various other distribution channels such as online platforms and medical supply distributors. The rise of e-commerce in the healthcare sector has made it easier for healthcare providers to access venous access ports and related products. Online platforms offer convenience, allowing providers to procure necessary devices quickly and efficiently. Additionally, medical supply distributors play a crucial role in ensuring that healthcare facilities have access to the latest venous access port technologies. The increasing trend of digitalization in healthcare and the demand for rapid access to medical supplies will sustain the relevance of this segment in the overall market.

By Material Type

Titanium Ports:

Titanium ports are renowned for their strength, durability, and biocompatibility, making them a preferred choice for many healthcare providers. The use of titanium in venous access ports minimizes the risk of infection and reduces the likelihood of port-related complications. Moreover, titanium ports are resistant to corrosion and wear, offering a long lifespan even under challenging conditions, such as in patients requiring long-term access. The increasing emphasis on patient safety and the quest for optimal healthcare outcomes will likely drive the demand for titanium ports in the venous access port market over the forecast period.

Silicone Ports:

Silicone ports are extensively used in venous access systems due to their flexibility, ease of handling, and excellent biocompatibility. These ports are designed to accommodate various therapeutic needs, ensuring comfort for patients during prolonged usage. Silicone's inert nature helps reduce the risk of adverse reactions, making it suitable for sensitive patient populations. The growing awareness of the benefits of silicone in terms of safety and comfort is expected to propel the demand for silicone ports in the market, particularly among patients undergoing long-term treatments.

Polyurethane Ports:

Polyurethane ports are known for their lightweight and strong properties, making them a viable option for various applications in venous access. These ports exhibit enhanced resistance to cracking and are less prone to damage compared to traditional materials. Polyurethane's advanced design helps improve flow rates, ensuring efficient drug delivery. As healthcare providers become more focused on optimizing patient care and outcomes, the demand for polyurethane ports is likely to increase, particularly among patients requiring frequent vascular access.

Stainless Steel Ports:

Stainless steel ports are another material option in the venous access port market, offering a robust and durable solution for various intravenous applications. The corrosion-resistant properties of stainless steel make these ports suitable for long-term use without compromising performance. Although stainless steel ports may not be as commonly utilized as other materials, they serve specific applications where strength and durability are paramount. As new applications emerge for venous access devices, stainless steel ports will continue to find relevance in the market.

Others:

The "Others" category includes ports made from various advanced or hybrid materials designed for specific patient needs or therapeutic applications. Innovations in materials science are driving the development of ports that maximize patient comfort and minimize complications. These specialized ports may include unique coatings or designs that cater to specific medical conditions or patient demographics. As healthcare providers increasingly seek tailored solutions, the demand for innovative port designs within the "Others" category is expected to grow, contributing to the overall expansion of the venous access port market.

By Region

The venous access port market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest market share, accounting for approximately 45% of the total market revenue in 2023. The region's dominance can be attributed to advanced healthcare infrastructure, high rates of chronic disease prevalence, and the presence of key market players. The CAGR for the North American market is projected to be around 7% during the forecast period, driven by ongoing innovations in venous access technologies and increasing patient awareness regarding the benefits of implantable ports.

Europe follows closely, representing around 30% of the global venous access port market. The European region is witnessing steady growth, fueled by an aging population and rising healthcare expenditure. Countries such as Germany, France, and the UK are at the forefront, investing in healthcare technologies to improve patient care. The Asia Pacific region is expected to exhibit the highest growth rate, with a CAGR of 9% during the forecast period. Factors contributing to this growth include increasing disposable incomes, improving healthcare facilities, and a growing population requiring long-term healthcare solutions. Latin America and the Middle East & Africa are also emerging markets for venous access ports, albeit at a slower pace, as these regions continue to enhance their healthcare systems.

Opportunities

As the demand for effective venous access solutions grows, numerous opportunities are emerging within the market. One significant opportunity lies in the development of advanced port technologies, such as smart ports equipped with monitoring capabilities. These innovative solutions can provide real-time data on port usage, fluid flow rates, and potential complications, enhancing patient safety and care. The integration of digital health technologies with venous access systems can help healthcare providers track treatment protocols and improve overall patient management. Manufacturers who invest in research and development to create more efficient, user-friendly, and technologically advanced devices will be well-positioned to capitalize on this trend.

Another noteworthy opportunity is the expanding application of venous access ports in homecare settings. As more patients seek healthcare solutions in their home environments, the demand for reliable and easy-to-use venous access devices will grow. Companies that can design ports specifically for home use—emphasizing ease of maintenance and patient education—will find a receptive market. Additionally, the increasing emphasis on personalized medicine and tailored treatment plans presents opportunities for manufacturers to develop specialized ports for unique patient demographics or health conditions, further driving market growth.

Threats

While the venous access port market is poised for growth, several threats could impact its trajectory. One such challenge is the risk of complications associated with venous access devices, including infections, thrombosis, and mechanical failure. As healthcare providers become more vigilant about patient safety, any increase in adverse events could lead to a decline in the adoption of venous access ports. Additionally, the presence of alternative vascular access devices, such as peripheral catheters and midline catheters, poses competitive pressure on the market. If healthcare providers identify these alternatives as sufficient for certain patient populations, the demand for venous access ports could be adversely affected.

Moreover, the regulatory landscape surrounding medical devices is becoming increasingly stringent, with manufacturers needing to comply with evolving regulations and standards. Delays in product approvals or challenges in navigating regulatory processes can hinder the timely introduction of new port technologies to the market. Furthermore, economic downturns and changes in healthcare reimbursement policies may limit hospitals' and clinics' budgets for purchasing advanced medical devices, potentially stalling market growth. Companies in the venous access port market must navigate these threats effectively to maintain a competitive edge.

Competitor Outlook

• Bard Medical
• Cook Medical
• Teleflex Incorporated
• Smiths Medical
• AngioDynamics, Inc.
• C.R. Bard, Inc.
• Halyard Health, Inc.
• BD (Becton, Dickinson and Company)
• Medtronic plc
• Vygon SA
• Boston Scientific Corporation
• Terumo Corporation
• Fresenius Kabi AG
• 3M Company
• Ameco Medical Industries

The competitive landscape of the venous access port market is characterized by several key players that dominate various segments. Companies are continuously innovating, launching new products, and expanding their portfolios to cater to the varying needs of healthcare providers and patients. Leading market players are increasingly focusing on enhancing the safety and efficiency of their products while also investing in research and development to bring advanced technologies to market. Collaborations and partnerships are prevalent among these companies, allowing them to leverage each other's strengths and expand their reach across different regions.

Bard Medical is one of the prominent players in the venous access port market, known for its extensive range of implantable ports and innovative access solutions. The company emphasizes research and development, focusing on improving patient outcomes through advanced port technologies. Cook Medical is another significant competitor, offering a diverse portfolio of venous access products, including specialized ports for oncology patients. Their commitment to quality and innovation positions them as a trusted provider in the market. Teleflex Incorporated is also noteworthy, recognized for its advanced catheter and port designs that enhance patient comfort and reduce complications.

Medtronic plc is a key player in the medical technology landscape with a strong presence in the venous access port market. The company continually invests in developing new technologies to provide efficient venous access solutions for patients requiring long-term treatment. Additionally, BD (Becton, Dickinson and Company) has established itself as a leader in the injection and infusion market, providing a range of venous access devices that prioritize safety and efficacy. Their dedication to improving healthcare outcomes through innovative medical devices drives their market presence. Overall, the competitive landscape of the venous access port market is dynamic, with key players striving to maintain their leadership positions while addressing emerging trends and patient needs.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Vygon SA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 3M Company
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Bard Medical
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Cook Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Smiths Medical
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 C.R. Bard, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Fresenius Kabi AG
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Terumo Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 AngioDynamics, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Halyard Health, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Teleflex Incorporated
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Ameco Medical Industries
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Venous Access Port Sales Market, By Application
    • 6.1.1 Chemotherapy
    • 6.1.2 Parenteral Nutrition
    • 6.1.3 Blood Transfusions
    • 6.1.4 Antibiotic Therapy
    • 6.1.5 Others
  • 6.2 Venous Access Port Sales Market, By Product Type
    • 6.2.1 Single-Lumen Ports
    • 6.2.2 Double-Lumen Ports
    • 6.2.3 Implantable Ports
    • 6.2.4 External Ports
    • 6.2.5 Others
  • 6.3 Venous Access Port Sales Market, By Material Type
    • 6.3.1 Titanium Ports
    • 6.3.2 Silicone Ports
    • 6.3.3 Polyurethane Ports
    • 6.3.4 Stainless Steel Ports
    • 6.3.5 Others
  • 6.4 Venous Access Port Sales Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Homecare Settings
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Venous Access Port Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Venous Access Port Sales market is categorized based on

By Product Type

• Single-Lumen Ports
• Double-Lumen Ports
• Implantable Ports
• External Ports
• Others

By Application

• Chemotherapy
• Parenteral Nutrition
• Blood Transfusions
• Antibiotic Therapy
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• Others

By Material Type

• Titanium Ports
• Silicone Ports
• Polyurethane Ports
• Stainless Steel Ports
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Bard Medical
• Cook Medical
• Teleflex Incorporated
• Smiths Medical
• AngioDynamics, Inc.
• C.R. Bard, Inc.
• Halyard Health, Inc.
• BD (Becton, Dickinson and Company)
• Medtronic plc
• Vygon SA
• Boston Scientific Corporation
• Terumo Corporation
• Fresenius Kabi AG
• 3M Company
• Ameco Medical Industries